Telix Pharmaceuticals Ltd reported 10.57M in Cost of Sales for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Cochlear COH:AU $ 195M 7.9M
CSL CSL:AU $ 3.24B 329.79M
Integral Diagnostics Ltd IDX:AU 9.92M 623K
Mayne Pharma MYX:AU $ 133.62M 29.86M
Opthea Ltd OPT:AU 50.76K 13.45K
Paradigm Biopharmaceuticals Ltd PAR:AU 73.1K 2.45K
Polynovo Ltd PNV:AU 1.33M 467.06K
Ramsay Health Care RHC:AU $ 1.83B 40.6M
ResMed RMD:AU $ 568.37M 195.07M
Sonic Healthcare SHL:AU $ 793.49M 17.47M